Support The Moscow Times!

Russia Expands Second Virus Vaccine’s Volunteer Pool Sixfold

Phase 3 trials of the Siberian-developed vaccine will involve 30,000 volunteers. Sofia Sandurskaya / Moskva News Agency

Russia’s second candidate vaccine against the coronavirus will be tested on six times the original number of volunteers as part of final clinical trials for safety and effectiveness, health authorities said Monday.

The government is expected to approve the peptide-based EpiVacCorona vaccine developed by a Siberian-based biotechnology company on or around Oct. 15. It completed trials last month on 100 volunteers who were said to be “feeling good.” 

“Centers for post-registration trials will be identified after the vaccine is registered and will involve 30,000 volunteers,” said consumer safety watchdog Rospotrebnadzor, according to Interfax.

Previous reporting said EpiVacCorona’s large-scale trials would only involve 5,000 volunteers in the Novosibirsk region.

Rospotrebnadzor said the first batch of 10,000 doses for “post-registration studies” will be released in late October. 

Once mass production begins, the vaccine “will be available to a wide range of citizens,” the watchdog added. 

The Novosibirsk-based Vektor State Virology and Biotechnology Center, a former Soviet bioweapons research lab and EpiVacCorona’s developer, says the vaccine will require booster doses every three years.

Though the Health Ministry is reviewing EpiVacCorona for “safety and quality,” The Wall Street Journal reported Monday that officials would not answer questions about trial results or the approval process.

Russia’s first registered Covid-19 vaccine, Sputnik V, began large-scale trials on 40,000 volunteers in September. Its developer, the Moscow-based Gamaleya research center, said this week that the trials will continue for around three to four months. 

Russia has seen its daily Covid-19 cases rise from under 5,000 in August to over 10,000 this week, stoking fears of a second wave similar to Europe's.

More than 1.22 million Covid-19 cases have been officially confirmed in Russia, the fourth-highest number of infections in the world.

… we have a small favor to ask.

As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just 2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

Continue

Read more